Pregnancy outcome in thoracic aortic disease data from the Registry Of Pregnancy And Cardiac disease

Cardiovascular disease is the leading cause of death during pregnancy with thoracic aortic dissection being one of the main causes. Thoracic aortic disease is commonly related to hereditary disorders and congenital heart malformations such as bicuspid aortic valve (BAV). Pregnancy is considered a hi...

Teljes leírás

Elmentve itt :
Bibliográfiai részletek
Szerzők: Campens Laurence
Baris Lucia
Scott Nandita S.
Kollaborációs szervezet: ROPAC investigators group
Temesvári A.
Bálint H.
Kőhalmi D.
Merkely B.
Liptai C.
Nemes Attila
Forster Tamás
Kalapos Anita
Berek K.
Havasi K.
Ambrus Nóra
Dokumentumtípus: Cikk
Megjelent: 2021
Sorozat:Heart (British Cardiac Society) 107 No. 21
Tárgyszavak:
doi:10.1136/heartjnl-2020-318183

mtmt:31967758
Online Access:http://publicatio.bibl.u-szeged.hu/23282
LEADER 02904nab a2200385 i 4500
001 publ23282
005 20220126093811.0
008 220126s2021 hu o 0|| Angol d
022 |a 1468-201X 
024 7 |a 10.1136/heartjnl-2020-318183  |2 doi 
024 7 |a 31967758  |2 mtmt 
040 |a SZTE Publicatio Repozitórium  |b hun 
041 |a Angol 
100 1 |a Campens Laurence 
245 1 0 |a Pregnancy outcome in thoracic aortic disease data from the Registry Of Pregnancy And Cardiac disease  |h [elektronikus dokumentum] /  |c  Campens Laurence 
260 |c 2021 
300 |a 1704-1709 
490 0 |a Heart (British Cardiac Society)  |v 107 No. 21 
520 3 |a Cardiovascular disease is the leading cause of death during pregnancy with thoracic aortic dissection being one of the main causes. Thoracic aortic disease is commonly related to hereditary disorders and congenital heart malformations such as bicuspid aortic valve (BAV). Pregnancy is considered a high risk period in women with underlying aortopathy.The ESC EORP Registry Of Pregnancy And Cardiac disease (ROPAC) is a prospective global registry that enrolled 5739 women with pre-existing cardiac disease. With this analysis, we aim to study the maternal and fetal outcome of pregnancy in women with thoracic aortic disease.Thoracic aortic disease was reported in 189 women (3.3%). Half of them were patients with Marfan syndrome (MFS), 26% had a BAV, 8% Turner syndrome, 2% vascular Ehlers-Danlos syndrome and 11% had no underlying genetic defect or associated congenital heart defect. Aortic dilatation was reported in 58% of patients and 6% had a history of aortic dissection. Four patients, of whom three were patients with MFS, had an acute aortic dissection (three type A and one type B aortic dissection) without maternal or fetal mortality. No complications occurred in women with a history of aortic dissection. There was no significant difference in median fetal birth weight if treated with a beta-blocker or not (2960 g (2358-3390 g) vs 3270 g (2750-3570 g), p value 0.25).This ancillary analysis provides the largest prospective data review on pregnancy risk for patients with thoracic aortic disease. Overall pregnancy outcomes in women with thoracic aortic disease followed according to current guidelines are good. 
650 4 |a Klinikai orvostan 
700 0 1 |a Baris Lucia  |e aut 
700 0 1 |a Scott Nandita S.  |e aut 
700 0 2 |a Kollaborációs szervezet: ROPAC investigators group  |e aut 
700 0 2 |a Temesvári A.  |e aut 
700 0 2 |a Bálint H.  |e aut 
700 0 2 |a Kőhalmi D.  |e aut 
700 0 2 |a Merkely B.  |e aut 
700 0 2 |a Liptai C.  |e aut 
700 0 2 |a Nemes Attila  |e aut 
700 0 2 |a Forster Tamás  |e aut 
700 0 2 |a Kalapos Anita  |e aut 
700 0 2 |a Berek K.  |e aut 
700 0 2 |a Havasi K.  |e aut 
700 0 2 |a Ambrus Nóra  |e aut 
856 4 0 |u http://publicatio.bibl.u-szeged.hu/23282/1/Campens2021.pdf  |z Dokumentum-elérés